HOME / NEWS /

2018

Cell therapy for all

November 1, 2018

Chad Cowan is on a quest for the universal donor, which would make cell therapy available to populations – not just individuals.

  • Harvard scientist Chad Cowan aims to make off-the-shelf cellular products, and democratize access to new medicines.
  • His lab is working to make cellular therapies that can work for anyone, not just a single patient. 
  • Their ambitious goal is to modify therapeutic cells that can be transplanted into many people, without being rejected.

...

Read more about Cell therapy for all

One good drug

November 1, 2018

HSCI physician-scientists Daniel Tenen and Li Chai want to turn off a gene to stop cancer without poisoning the patient.

  • The ideal cancer drug would harm cancer cells without hurting normal cells.
  • In their quest to discover one good therapy, HSCI scientists Dan Tenen and Li Chai have zeroed in on SALL4, a gene that is essential for growth in both embryos and cancers.
  • A cellular therapy that deprives cancer cells of SALL4 would stop a third of cancers in their tracks.

Download PDF of this story

... Read more about One good drug

HSCI forms collaboration with Qatar Biomedical Research Institute

October 8, 2018

HSCI has signed a collaborative research and training agreement with Qatar Biomedical Research Institute (QBRI), a research institute under Hamad Bin Khalifa University (HBKU). The five-year initiative includes technical training and research in stem cell biology, with the goal of working toward viable treatments for diabetes.

The prevalence of type 1 and 2 diabetes is a rising global healthcare challenge. Recent advances in stem cell research, led by HSCI scientists, have the potential to help both type 1 and type 2 diabetes patients cope with their condition by...

Read more about HSCI forms collaboration with Qatar Biomedical Research Institute